Supplementary Material for: Anti-<b><i>Ascaris</i></b> IgE as a Risk Factor for Asthma Symptoms among 5-Year-Old Children in Rural Bangladesh with Even Decreased <b><i>Ascaris</i></b> Infection Prevalence by Takeuchi H. (12022622)

“…<b><i>Methods:</i></b> A total of 126 children aged 5 years with wheezing during the previous year and 110 children who did not have wheezing were selected randomly from the rural service area of the International Centre for Diarrhoeal Disease Research, Bangladesh. …”

Reaction products formed after incubation of pooled fractions T_I-V from <i>T</i>. <i>molitor</i> with substrates L-tyrosine and L-DOPA; + formed, × not found, = substrate constant, − substrates decreases, n/a not applicable. by Renske H. Janssen (1861423)

“…<p>Reaction products formed after incubation of pooled fractions T_I-V from <i>T</i>. <i>molitor</i> with substrates L-tyrosine and L-DOPA; + formed, × not found, = substrate constant, − substrates decreases, n/a not applicable.…”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Loss of Rumi leads to intracellular accumulation and decreased IRS levels of Eys in a temperature dependent manner at the mid-pupal stage. by Amanda R. Haltom (664189)

“…The scale bar in A applies to A–G′ and is 5 µm. (A,A′) A wild-type ommatidium at 55% PD raised at 18°C. …”

Synthesis of (Imido)vanadium(V) Complexes Containing 8‑(2,6-Dimethylanilide)-5,6,7-trihydroquinoline Ligands: Highly Active Catalyst Precursors for Ethylene Dimerization by Xiao-Yan Tang (147869)

“…A series of (imido)­vanadium­(V) dichloride complexes containing 8-(2,6-dimethylanilide)-5,6,7-trihydroquinoline ligands of the type V­(NR)­Cl₂[8-(2,6-Me₂C₆H₃)­N­(C₉H₁₀N)] (R = Ad (<b>3</b>), 2-MeC₆H₄ (<b>4</b>), 2,6-Me₂C₆H₃ (Ar, <b>5</b>)) have been prepared and identified, and their structures have been determined by X-ray crystallographic analysis. …”

Protection of Aβ-mediated neuronal cell death by sRAGE, pyridoxamine or ALT-711 through decreasing RAGE levels. by Kyunghee Byun (162379)

“…(C) Triple confocal microscopic images simultaneously show the relative numbers of AGE, albumin, or Iba1 positive cells in the rat entorhinal cortex (EC) before or after Aβ or Aβ/sRAGE injection for 72 h. These results represent similar images of 5 independent analyses. …”

Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf by Yi Li (1144)

“…Data were pooled under a random- or fixed-effects model using RevMan 5.4 with odds ratio (OR) and 95% confidence interval (CI) as the effect measures.…”

List of the main semi-quantified compounds (% area) from pyrolysis of A, M2.5, M5, M10 at 450ºC, 550º and 650ºC. by Sueilha F. A. Paula (13988800)

Description of columns in S5 Table. by Thomas J. C. Sauters (17382864)

Recombinant SFRP3 decreases migration and invasion of melanoma cells. by Elin J. Ekström (225100)

Decreased echinocandin susceptibility in <i>Candida parapsilosis</i> causing candidemia and emergence of a pan-echinocandin resistant case in China by Yating Ning (11264310)

Cell proliferation is significantly decreased by age in the mouse hippocampal DG. by Joana Gil-Mohapel (462002)

Comparison of wind roses between ERA5 reanalysis and in-situ measured data. a: W03 station, b: W08 station, c: W13 station and d: W19 station. by Weidong Ji (129916)

Expression of WT Dyskerin can rescue dysfunctional telomerase in <i>ΔL37</i> cells but not in <i>A353V</i> cells. by Bai-Wei Gu (740949)

Treatment with anti-JAM-C antibody decreases the T-cell response by Gaby Palmer (636)

Image2_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF by Boao Xie (11621803)

“…IL-33 plays a role in venous neointimal hyperplasia both in humans and rats; neutralization of IL-33 by IL-33 antibody can be a therapeutic method to decrease venous neointimal hyperplasia.…”